[1] |
DENG Jiayi, HU Weixin.
Application of angiotensin Ⅱ type 1 receptor autoantibodies in renal diseases
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(6): 579-584.
|
[2] |
CHEN Duqun, CHEN Yinghua, LOU Lixuan, LIU Zhengzhao, ZHANG Haitao, XIE Honglang, HU Weixin.
Reduced dose rituximab for refractory lupus nephritis: a preliminary observational study
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(5): 401-406.
|
[3] |
HUANG Weiwei, DONG Jianhua, CHENG Shuiqin, LI Zhe, LUO Song, MA Yan, ZHANG Lingyan, ZHANG Jun, ZHI Beibei, QI Li, HU Weixin, SUN Zhiyuan.
Cardiac magnetic resonance diffusion weighted imaging in lupus nephritis patients with myocardial injury
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(4): 317-322.
|
[4] |
ZHAO Yue, ZHANG Mingchao, LIANG Shaoshan, QIN Weisong, LIU Zhihong.
The protective effect and mechanism of chrysin on MRL/lpr lupus mice
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(4): 323-327.
|
[5] |
ZHAO Yue, ZHENG Zuguo, ZHOU Ping, LI Ping, LIU Zhihong.
Establishment and application of a high-throughput screening model for Toll-like receptor 7 inhibitors
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(3): 223-230.
|
[6] |
CHEN Duqun, CHEN Yinghua, LOU Lixuan, GAO Erzhi, WANG Xia, REN Guisheng, LIU Zhengzhao, ZHANG Haitao, HU Weixin.
Ultra-low dose rituximab regimen for treatment of lupus nephritis: an observational study
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(2): 101-107.
|
[7] |
MIN Min, HU Weixin, ZHANG Haitao, LIU Zhengzhao, CHENG Zhen, WANG Jinquan, ZHANG Jiong.
闵敏,胡伟新,章海涛,刘正钊,程震,王金泉,张炯
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(2): 126-132.
|
[8] |
WANG Chengyu, HU Weixin.
Podocyte injury in lupus nephritis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(6): 571-574.
|
[9] |
DU Mengru, ZHANG Lihua, WU Xiaomei, LIU Zhihong, XIE Honglang.
Double negative T cells in peripheral blood of patients with lupus nephritis: The relation to disease activity and therapeutic effect
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(5): 407-413.
|
[10] |
HU Ziyun, LI Lijuan, CHEN Dacheng, LIANG Dandan, LIANG Shaoshan, XU Feng, ZENG Caihong.
Application of antiphosphatidylserine/prothrombin antibodies and criteria antiphospholipid antibodies in lupus nephritis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(5): 414-419.
|
[11] |
DONG Jianhua, HUANG Li, LI Chuan, KONG Ling, HUANG Lixuan, FAN Wenjing, WU Bian, HU Weixin, GE Yongchun.
The centrifugal-membranous hybrid double filtration plasmapheresis therapy for severe lupus nephritis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(4): 305-314.
|
[12] |
MIAO Yiqi, LI Zhe, XU Shutian, ZHOU Yuchao, ZHOU Yun, WANG Yang, LI Shijun, HU Weixin.
Clinical characteristics and outcomes of critical patients with active lupus nephritis in renal intensive care unit
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(4): 321-326.
|
[13] |
ZHU Yan, PENG Lin, ZHANG Mingchao, WANG Lizhi, XU Xiaodong, ZENG Caihong, QIN Weisong, LIU Zhihong.
Experimental study of receptor interaction protein kinase 1 inhibitor (necrostatin-1) in treatment of lupus nephritis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(3): 239-245.
|
[14] |
XU Cheng, CHEN Zhaohong.
Role of nuclear factor erythroid 2related factor 2 in kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(2): 165-169.
|
[15] |
XIE Minzhu, CHEN Xin, LIU Zhengzhao, ZHANG Haitao, LUO Song, HU Weixin.
Clinical characteristics and longterm outcomes in patients and nephritis with lupus enteritis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(1): 19-24.
|